(Q40581666)

21 September 2017

1 reference

title

The hibernating myocardium: implications for management of congestive heart failure (English)

1 reference

21 September 2017

0 references

hibernating myocardium

1 reference

based on heuristic

litr

congestive heart failure

1 reference

R O Bonow

1

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

American Journal of Cardiology

21 September 2017

published in

1 reference

21 September 2017

volume

75

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

17A-25A

1 reference

Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II. Ventriculographic and other correlations.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Survival in medically treated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Survival of medically treated patients in the coronary artery surgery study (CASS) registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Coronary bypass surgery for chronic angina--1981. A perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

The hibernating myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Current status of viability assessment with positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Insights into coronary artery disease gained from metabolic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Thallium-201 for assessment of myocardial viability: quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Postextrasystolic Potentiation as a Predictor of Potential Myocardial Viability: Preoperative Analyses Compared With Studies After Coronary Bypass Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980379-8

10.1016/S0002-9149(99)80379-8

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference